Intuitive Surgical Inc (NASDAQ:ISRG) — Market Cap & Net Worth
Market Cap & Net Worth: Intuitive Surgical Inc (ISRG)
Intuitive Surgical Inc (NASDAQ:ISRG) has a market capitalization of $145.58 Billion ($145.58 Billion) as of June 15, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #162 globally and #91 in its home market, demonstrating a -1.85% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Intuitive Surgical Inc's stock price $411.06 by its total outstanding shares 354162842 (354.16 Million). Review ISRG total debt and obligations to assess the company's total debt and financial obligations.
Intuitive Surgical Inc Market Cap History: 2015 to 2026
Intuitive Surgical Inc's market capitalization history from 2015 to 2026. Data shows growth from $21.49 Billion to $145.58 Billion (21.16% CAGR).
Index Memberships
Intuitive Surgical Inc is a constituent of 5 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$61.85 Trillion | 0.39% | #76 of 503 |
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 5.98% | #4 of 976 |
|
NASDAQ Composite
IXIC
|
$40.95 Trillion | 0.36% | #35 of 3165 |
|
Nasdaq 100
NDX
|
$34.23 Trillion | 0.43% | #32 of 101 |
|
S&P 100
OEX
|
$44.22 Trillion | 0.56% | #63 of 101 |
Weight: Intuitive Surgical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Intuitive Surgical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Intuitive Surgical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
19.93x
Intuitive Surgical Inc's market cap is 19.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
70.23x
Intuitive Surgical Inc's market cap is 70.23 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $24.96 Billion | $2.70 Billion | $735.90 Million | 9.23x | 33.91x |
| 2017 | $43.08 Billion | $3.13 Billion | $660.00 Million | 13.77x | 65.28x |
| 2018 | $56.54 Billion | $3.72 Billion | $1.13 Billion | 15.18x | 50.13x |
| 2019 | $69.79 Billion | $4.48 Billion | $1.38 Billion | 15.58x | 50.60x |
| 2020 | $96.58 Billion | $4.36 Billion | $1.06 Billion | 22.16x | 91.06x |
| 2021 | $127.25 Billion | $5.71 Billion | $1.70 Billion | 22.29x | 74.65x |
| 2022 | $93.98 Billion | $6.22 Billion | $1.32 Billion | 15.10x | 71.07x |
| 2023 | $119.48 Billion | $7.12 Billion | $1.80 Billion | 16.77x | 66.45x |
| 2024 | $184.86 Billion | $8.35 Billion | $2.32 Billion | 22.13x | 79.59x |
| 2025 | $200.58 Billion | $10.06 Billion | $2.86 Billion | 19.93x | 70.23x |
Competitor Companies of ISRG by Market Capitalization
Companies near Intuitive Surgical Inc in the global market cap rankings as of June 15, 2026.
Key companies related to Intuitive Surgical Inc by market ranking:
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $98.90 Billion USD ( €84.60 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #344 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #537 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #671 globally with a market cap of $40.30 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #258 | EssilorLuxottica S. A. | PA:EL | $98.90 Billion | €182.70 |
| #344 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €90.00 |
| #537 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
| #671 | Becton Dickinson and Company | NYSE:BDX | $40.30 Billion | $146.24 |
Intuitive Surgical Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Intuitive Surgical Inc's market cap moved from $21.49 Billion to $ 145.58 Billion, with a yearly change of 21.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $145.58 Billion | -27.42% |
| 2025 | $200.58 Billion | +8.51% |
| 2024 | $184.86 Billion | +54.72% |
| 2023 | $119.48 Billion | +27.14% |
| 2022 | $93.98 Billion | -26.15% |
| 2021 | $127.25 Billion | +31.76% |
| 2020 | $96.58 Billion | +38.39% |
| 2019 | $69.79 Billion | +23.43% |
| 2018 | $56.54 Billion | +31.23% |
| 2017 | $43.08 Billion | +72.64% |
| 2016 | $24.96 Billion | +16.11% |
| 2015 | $21.49 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 15th, 2026 the market cap of Intuitive Surgical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $145.58 Billion USD |
| MoneyControl | $145.58 Billion USD |
| MarketWatch | $145.58 Billion USD |
| marketcap.company | $145.58 Billion USD |
| Reuters | $145.58 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings… Read more